The Future Of MilliporeSigma's Gene Therapy CDMO Through The Lens Of History

Today, MilliporeSigma’s BioReliance® Viral Vector Manufacturing Services offer innovators process development, clinical and commercial GMP manufacturing and testing services.

On the road to becoming a global industry leader in cell and gene therapy, our viral vector manufacturing organization has undergone a major transformation over the last two decades. Marc Gaal, Director of Program Management at MilliporeSigma, details the history of the business as well as some of the milestones achieved since its inception.